Recurrent Hepatitis C
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection (NCT00582738) | Novartis Pharmaceuticals | 2007-12-01 |
Track Recurrent Hepatitis C automatically
Every clearance here is in the API, with alerts when new ones post.